Divence Penta

Authorised

This medicine is authorised for use in the European Union

bovine parainfluenza virus 3, strain SF-4 Reisinger, inactivated / bovine respiratory syncytial virus, strain LYM-56, live / bovine viral diarrhoea virus 1, E2 recombinant protein / bovine viral diarrhoea virus 2, E2 recombinant protein / infectious bovine rhinotracheitis virus, strain CEDDEL, gE- tk- double-gene deleted, live

Overview

Up-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website

Product details

• Name of medicine:
  Divence Penta
• Active substance:
  • bovine parainfluenza virus 3, strain SF-4 Reisinger, inactivated
  • live attenuated bovine respiratory syncytial virus (BRSV), strain Lym-56
  • bovine viral diarrhoea virus 1, E2 recombinant protein
  • bovine viral diarrhoea virus 2, E2 recombinant protein
  • infectious bovine rhinotracheitis virus, strain CEDDEL, gE- tk- double-gene deleted, live
• International non-proprietary name (INN) or common name:
  • bovine parainfluenza virus 3, strain SF-4 Reisinger, inactivated
  • bovine respiratory syncytial virus, strain LYM-56, live
  • bovine viral diarrhoea virus 1, E2 recombinant protein
  • bovine viral diarrhoea virus 2, E2 recombinant protein
  • infectious bovine rhinotracheitis virus, strain CEDDEL, gE- tk- double-gene deleted, live

Pharmacotherapeutic group

• Immunologicals for Bovidae
• Live and inactivated viral vaccines

Authorisation details

• EMA product number:
  EMEA/V/C/006175

Assessment history

Initial marketing authorisation documents

CVMP summary of positive opinion for Divence Penta

Reference Number: EMA/CVMP/43998/2024